Comparison of Enhancement of the Vestibular Perilymph between Variable and Constant Flip Angle–Delayed 3D-FLAIR Sequences in Menière Disease

References

1. 1.↵
   1. Altmann F,
   2. Fowler EP Jr..

   Histological findings in Meniere’s symptom complex. Ann Otol Rhinol Laryngol 1943;52:52–80
2. 2.↵
   1. Nakashima T,
   2. Naganawa S,
   3. Pyykko I, et al

   . Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Oto-Laryngol Suppl 2009:5–8 doi:10.1080/00016480902729827 pmid:19221900

   CrossRefPubMed
3. 3.↵
   1. Tagaya M,
   2. Yamazaki M,
   3. Teranishi M, et al

   . Endolymphatic hydrops and blood-labyrinth barrier in Ménière’s disease. Acta Otolaryngol 2011;131:474–79 doi:10.3109/00016489.2010.534114 pmid:21198346

   CrossRefPubMed
4. 4.↵
   1. Attyé A,
   2. Eliezer M,
   3. Boudiaf N, et al

   . MRI of endolymphatic hydrops in patients with Meniere’s disease: a case-controlled study with a simplified classification based on saccular morphology. Eur Radiology 2017;27:3138–46 doi:10.1007/s00330-016-4701-z pmid:27999985

   CrossRefPubMed
5. 5.↵
   1. Bernaerts A,
   2. Vanspauwen R,
   3. Blaivie C, et al

   . The value of four stage vestibular hydrops grading and asymmetric perilymphatic enhancement in the diagnosis of Menière’s disease on MRI. Neuroradiology 2019;61:421–29 doi:10.1007/s00234-019-02155-7 pmid:30719545

   CrossRefPubMed
6. 6.↵
   1. Naganawa S,
   2. Komada T,
   3. Fukatsu H, et al

   . Observation of contrast enhancement in the cochlear fluid space of healthy subjects using a 3D-FLAIR sequence at 3 Tesla. Eur Radiol 2006;16:733–37 doi:10.1007/s00330-005-0046-8 pmid:16267664

   CrossRefPubMed
7. 7.↵
   1. Naganawa S,
   2. Yamazaki M,
   3. Kawai H, et al

   . Visualization of endolymphatic hydrops in Ménière’s disease with single-dose intravenous gadolinium-based contrast media using heavily T(2)-weighted 3D-FLAIR. Magn Reson Med Sci 2010;9:237–42 doi:10.2463/mrms.9.237 pmid:21187694

   CrossRefPubMed
8. 8.↵
   1. Yamazaki M,
   2. Naganawa S,
   3. Tagaya M, et al

   . Comparison of contrast effect on the cochlear perilymph after intratympanic and intravenous gadolinium injection. AJNR Am J Neuroradiol 2012;33:773–78 doi:10.3174/ajnr.A2821 pmid:22173762

   Abstract/FREE Full Text
9. 9.↵
   1. Li Y,
   2. Sha Y,
   3. Wang F, et al

   . Comprehensive comparison of MR image quality between intratympanic and intravenous gadolinium injection using 3D real IR sequences. Acta Otolaryngol 2019;139:659–64 doi:10.1080/00016489.2019.1600719 pmid:31130050

   CrossRefPubMed
10. 10.↵
    1. Naganawa S

    . The technical and clinical features of 3D-FLAIR in neuroimaging. Magn Reson Med Sci 2015;14:93–106 doi:10.2463/mrms.2014-0132 pmid:25833275

    CrossRefPubMed
11. 11.↵
    1. Naganawa S,
    2. Yamazaki M,
    3. Kawai H, et al

    . Imaging of Ménière’s disease after intravenous administration of single-dose gadodiamide: utility of subtraction images with different inversion time. Magn Reson Med Sci 2012;11:213–19 doi:10.2463/mrms.11.213 pmid:23037568

    CrossRefPubMed
12. 12.↵
    1. Sepahdari AR,
    2. Ishiyama G,
    3. Vorasubin N, et al

    . Delayed intravenous contrast-enhanced 3D FLAIR MRI in Meniere’s disease: correlation of quantitative measures of endolymphatic hydrops with hearing. Clin Imaging 2015;39:26–31 doi:10.1016/j.clinimag.2014.09.014 pmid:25457542

    CrossRefPubMed
13. 13.↵
    1. Eliezer M,
    2. Maquet C,
    3. Horion J, et al

    . Detection of intralabyrinthine abnormalities using post-contrast delayed 3D-FLAIR MRI sequences in patients with acute vestibular syndrome. Eur Radiol 2019;29:2760–69 doi:10.1007/s00330-018-5825-0 pmid:30413960

    CrossRefPubMed
14. 14.↵
    1. Pakdaman MN,
    2. Ishiyama G,
    3. Ishiyama A, et al

    . Blood-labyrinth barrier permeability in Menière disease and idiopathic sudden sensorineural hearing loss: findings on delayed postcontrast 3D-FLAIR MRI. AJNR Am J Neuroradiol 2016;37:1903–08 doi:10.3174/ajnr.A4822 pmid:27256854

    Abstract/FREE Full Text
15. 15.↵
    1. Mugler JP

    . Optimized three-dimensional fast-spin-echo MRI. J Magn Reson Imaging 2014;39:745–67 doi:10.1002/jmri.24542 pmid:24399498

    CrossRefPubMed
16. 16.↵
    1. Naganawa S,
    2. Kawai H,
    3. Sone M, et al

    . Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3D-FLAIR to visualize endolymphatic space. Magn Reson Med Sci 2010;9:73–80 doi:10.2463/mrms.9.73 pmid:20585197

    CrossRefPubMed
17. 17.↵
    Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss: American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:186–87 doi:10.1016/S0194-5998(95)70103-6 pmid:7675477

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Eliezer M,
    2. Poillon G,
    3. Gillibert A, et al

    . Comparison of enhancement of the vestibular perilymph between gadoterate meglumine and gadobutrol at 3-Tesla in Meniere’s disease. Diagn Interv Imaging 2018;99:271–77 doi:10.1016/j.diii.2018.01.002 pmid:29398574

    CrossRefPubMed
19. 19.↵
    1. Merchant SN,
    2. Nadol JB

    . Schuknecht’s Pathology of the Ear. 3rd ed. Shelton: McGraw-Hill Medical; 2010
20. 20.↵
    1. Lane JI,
    2. Witte RJ,
    3. Bolster B, et al

    . State of the art: 3T imaging of the membranous labyrinth. AJNR Am J Neuroradiol 2008;29:1436–40 doi:10.3174/ajnr.A1036 pmid:18388217

    Abstract/FREE Full Text
21. 21.↵
    1. Naganawa S,
    2. Kawai H,
    3. Taoka T, et al

    . Cochlear lymph fluid signal increase in patients with otosclerosis after intravenous administration of gadodiamide. Magn Reson Med Sci 2016;15:308–15 doi:10.2463/mrms.mp.2015-0121 pmid:26841857

    CrossRefPubMed
22. 22.↵
    1. Byun H,
    2. Chung JH,
    3. Lee SH, et al

    . The clinical value of 4-hour delayed-enhanced 3D-FLAIR MR images in sudden hearing loss. Clin Otolaryngol 2019;44:336–42 doi:10.1111/coa.13305 pmid:30729710

    CrossRefPubMed
23. 23.↵
    1. Eliezer M,
    2. Toupet M,
    3. Guichard J-P, et al

    . Cochleovestibular artery syndrome: consideration based on VHIT, VEMP, and inner ear MRI. J Neurol 2019;266:2327–29 doi:10.1007/s00415-019-09407-9 pmid:31152299

    CrossRefPubMed
24. 24.↵
    1. Eliezer M,
    2. Verillaud B,
    3. Guichard J-P, et al

    . Labyrinthine infarction caused by vertebral artery dissection: consideration based on MRI. J Neurol 2019;266:2575–77 doi:10.1007/s00415-019-09456-0 pmid:31267205

    CrossRefPubMed
25. 25.↵
    1. Kahn L,
    2. Hautefort C,
    3. Guichard JP, et al

    . Relationship between video head impulse test, ocular and cervical vestibular evoked myogenic potentials and compartmental magnetic resonance imaging classification in Menière’s disease. Laryngoscope 2019 Nov 19. [Epub ahead of print] doi:10.1002/lary.28362 pmid:31742710

    CrossRefPubMed
26. 26.↵
    1. Barath K,
    2. Schuknecht B,
    3. Naldi AM, et al

    . Detection and grading of endolymphatic hydrops in Menière disease using MR imaging. AJNR Am J Neuroradiol 2014;35:1387–92 doi:10.3174/ajnr.A3856 pmid:24524921

    Abstract/FREE Full Text
27. 27.↵
    1. Pyykkö I,
    2. Nakashima T,
    3. Yoshida T, et al

    . Meniere’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops. BMJ Open 2013;3:e001555 doi:10.1136/bmjopen-2012-001555

    Abstract/FREE Full Text
28. 28.↵
    1. Eliezer M,
    2. Attyé A,
    3. Guichard JP, et al

    . Vestibular atelectasis: myth or reality?. Laryngoscope 2019;129:1689–95 doi:10.1002/lary.27793 pmid:30632154

    CrossRefPubMed
29. 29.↵
    1. Sajjadi H,
    2. Paparella MM

    . Meniere’s disease. Lancet 2008;372:406–14 doi:10.1016/S0140-6736(08)61161-7 pmid:18675691

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Sood AJ,
    2. Lambert PR,
    3. Nguyen SA, et al

    . Endolymphatic sac surgery for Ménière’s disease: a systematic review and meta-analysis. Otol Neurotol 2014;35:1033–45 doi:10.1097/MAO.0000000000000324 pmid:24751747

    CrossRefPubMed
31. 31.↵
    1. Tewary AK,
    2. Riley N,
    3. Kerr AG

    . Long-term results of vestibular nerve section. J Laryngol Otol 1998;112:1150–53 doi:10.1017/s0022215100142719 pmid:10209610

    CrossRefPubMed
32. 32.↵
    1. Miller MW,
    2. Agrawal Y

    . Intratympanic therapies for Menière’s disease. Curr Otorhinolaryngol Rep 2014;2:137–43 doi:10.1007/s40136-014-0055-8 pmid:25215266

    CrossRefPubMed